Drug Database
Back to search

Poland· PL-100430832

Myditin

A pridinol product containing pridinolum, registered in Poland by Sun-Farm Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC M03BX03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMyditinATCM03BX03REGISTER NO.PL-100430832PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pridinolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pridinol is registered in 5 of 19 countries.

Countries holding a registration under ATC M03BX03 (pridinol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search pridinol products by name

Pridinol · ATC M03BX03

5 / 19 countries

  • Germany
  • Japan
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pridinolum
Manufacturer
Sun-Farm Sp. z o.o.
Country
Poland (PL)
ATC code
M03BX03
ATC class
Pridinol
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991431297
  • gtin
    05907464420809

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pridinol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pridinol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Myopridin
  • Germany · Myditin, Myopridin
  • Spain · Myditin
  • United Kingdom (Northern Ireland) · Myopridin
  • Italy · Myditin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/58f6bc6b-d5bf-4d37-9070-01a663044260
GET /v1/drugs/58f6bc6b-d5bf-4d37-9070-01a663044260?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "3 mg",
  "packaging": "05909991431297 ¦ Rp ¦ 136536\n20 tabl.\n05907464420809 ¦ Rp ¦ 145775\n50 tabl.",
  "substance": "Pridinol mesylate 3 mg",
  "common_name": "Pridinolum",
  "pl_product_id": "100430832",
  "pozwolenie_nr": "25914",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about pridinol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console